Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Trials, trips, and tribulations: pathways for implementing psychedelic therapy in IrelandThe International Journal of Neuropsychopharmacology · 2026-05-08The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomesMental Wellness · 2026-04-20Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanismsNeuropharmacology · 2026-01-20Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled TrialsJournal of Clinical Medicine · 2025-12-28Metastability of resting-state bold fMRI as a reliable biomarker of individual brain dynamics: An interrogation of within-subject variability as a function of total acquisition timeNetwork Neuroscience · 2025-12-08A comparative assessment of the antidepressant efficacy of ketamine, psilocybin, and fluoxetine in a chronic stress modelScientific Reports · 2025-11-25Exploring the first use of psychedelic macrodoses in Latin American adults: Sociodemographic profiles, consumption factors, and subjective experiencesJournal of Psychedelic Studies · 2025-11-19The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female MiceJournal of Neuroscience · 2025-11-09Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trialsNeuropharmacology · 2025-10-16Towards Novel Antidepressant Strategies: A Comparative Study of Ketamine, Psilocybin, and Fluoxetine in a Chronic Stress ModelResearch Square · 2025-10-06S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-18Psilocybin: Systematic review of its use in the treatment of depressionUnknown journal · 2025-08-25The Causal Role of Consciousness in Psychedelic Therapy for Treatment-Resistant Depression: Hypothesis and ProposalACS Pharmacology & Translational Science · 2025-07-15Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paperEuropean Psychiatry · 2024-12-31PolDrugs 2025: results of the third edition of the nationwide study on psychoactive substance use in the context of psychiatry and harm reduction.Frontiers in psychiatry · 2024-12-31Pattern of psychedelic substance use: a comparison between populations in Spain and South America using the Psychedelic Use Scale (PUS)Current Psychology · 2024-11-20Latin American adults who regularly use macrodoses of psychedelics: a cross-sectional studyResearch Square · 2024-07-31Prefrontal Electrophysiological Biomarkers and Mechanism-Based Drug Effects in a Rat Model of Alcohol AddictionResearch Square · 2024-02-21Introduction to the Special Section on Psychedelics Research and TreatmentPerspectives in biology and medicine · 2023-12-31Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational studyExpert Review of Clinical Pharmacology · 2023-12-17Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocolEuropean Journal of Trauma & Dissociation · 2023-10-24Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memoriesPsychopharmacology · 2023-06-01Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.Unknown journal · 2023-03-21Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and TreatmentPerspectives in biology and medicine · 2022-12-31Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.Journal of Personalized Medicine · 2022-06-18An Overview on the Taxonomy, Phylogenetics and Ecology of the Psychedelic Genera Psilocybe, Panaeolus, Pluteus and GymnopilusFrontiers in Forests and Global Change · 2022-05-22Novel antidepressant drugs: Beyond monoamine targets.Unknown journal · 2021-09-29Ethics and ego dissolution: the case of psilocybinJournal of Medical Ethics · 2020-05-26Attitudes Toward Medical PsychedelicsDominican Scholar (Dominican University of California) · 2019-04-17Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.Psychopharmacology · 2018-01-04PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary reportThe International Journal of Neuropsychopharmacology · 2016-05-26PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEGThe International Journal of Neuropsychopharmacology · 2016-05-26The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD)European Psychiatry · 2016-02-29Electrocardiographic examination of heart function in rats exposed to hallucinogens from Psilocybe mushroomsActa Toxicologica · 2002-12-31